Dosage ; Orally: adults; 20mg QID,
child 6-12 years; 5-10mg TID,
infants; 5mg TID. I.M:
Acute spasm: 20mg repeated over 30 minutes when required
| Brand Name | Manufacturer Name | Distributor | Drug Strength | Packaging | Formulation | Formulation Strength | Price |
|---|---|---|---|---|---|---|---|
| Buscopan | Boehringer Ingelheim International | Jos Hansen (E.A) Ltd | 10mg | 50 | Tablet | per tablet | KES 710 |
| Buscopan | Boehringer Ingelheim International | Jos Hansen (E.A) Ltd | 10mg | 5 | Injection | per ml | KES 532 |
| Buscopan | Boehringer Ingelheim International | Jos Hansen (E.A) Ltd | 10mg | 100 | Tablet | per tablet | KES 240 |
| Buscopan | Boehringer Ingelheim International | Jos Hansen (E.A) Ltd | 10mg | 1000 | Tablet | per tablet | KES 2,200 |
| Buscopan | Boehringer Ingelheim International | Jos Hansen (E.A) Ltd | 60ml | Liquid | per 5ml | KES 75 | |
| Duxcospan | Universal Pharmaceuticals Ltd. | Europa Healthcare Ltd. | 10mg | 100 | Tablet | per tablet | KES 1,053.00 |
| Duxcospan | Universal Pharmaceuticals Ltd. | Europa Healthcare Ltd. | 5mg | 60ml | Syrup | per 5ML | KES 90.00 |
| Duxcospan | Universal Pharmaceuticals Ltd. | Europa Healthcare Ltd. | 10mg | 1000 | Tablet | per tablet | KES 10,312.00 |
| Hayocin | OSS-Chemie k Ltd | Njimia Pharmaceuticals Ltd. | 60ml | Liquid | per 5ml | KES 39 | |
| Hayocin | OSS-Chemie k Ltd | Njimia Pharmaceuticals Ltd. | 100ml | Liquid | per 5ml | KES 77 | |
| Hyomide | Flamingo Heat Pad | Harley's Limited | 10mg | 100 | Tablet | per tablet | KES 240.00 |
| Hyomide | Flamingo Heat Pad | Harley's Limited | 10mg | 1000 | Tablet | per tablet | KES 1,700.00 |
| Hyoscine | Laborate | Harley's Limited | 20mg | 1ml | Injection | per ml | KES 15.00 |
| Hyospan | Biodeal Laboratories Ltd. | Biodeal Laboratories Ltd. | 10mg | 100 | Tablet | per tablet | KES 240.00 |
| Hyospan | Biodeal Laboratories Ltd. | Biodeal Laboratories Ltd. | 10mg | 1000 | Tablet | per tablet | KES 2,200.00 |
| Hyospan | Biodeal Laboratories Ltd. | Biodeal Laboratories Ltd. | 60ml | Liquid | per 5ml | KES 75 | |
| Hyscin | Dawa Limited | Dawa Limited | 60ml | Syrup | per 5ML | KES 55 | |
| Hyscin | Dawa Limited | Dawa Limited | 10mg | 100 | Tablet | per tablet | KES 285 |
| Hyscin | Dawa Limited | Dawa Limited | 10mg | 1000 | Tablet | per tablet | KES 2,200 |
| Hyscin | Dawa Limited | Dawa Limited | 20mg | 1ml | Injection | per ml | KES 15 |
| Hyscopan | Globe Pharmacy Ltd., | Globe Pharmacy Ltd., | 20mg | 1ml | Injection | per ml | KES 14.70 |
| Nospasum | Laboratory & Allied Ltd. | Laboratory & Allied Ltd | 10mg | 100 | Tablet | per tablet | KES 425.00 |
| Nospasum | Laboratory & Allied Ltd. | Laboratory & Allied Ltd | 10mg | 1000 | Tablet | per tablet | KES 3,500.00 |
| Nospasum | Laboratory & Allied Ltd. | Laboratory & Allied Ltd | 60ml | Liquid | per 5ml | KES 45 | |
| Nospasum | Laboratory & Allied Ltd. | Laboratory & Allied Ltd | 20mg | 1ml | Injection | per vial | KES 13.00 |
| Spanil | Beximco Pharma | Madawa Pharmaceuticals Ltd. | 10mg | 100 | Tablet | per tablet | KES 2,052.00 |
| Hyoscine butylbromide | Cosmos Limited. | Cosmos Limited | 10mg | 100 | Tablet | per tablet | KES 2,400.00 |
| Hyoscine butylbromide | Laboratory & Allied Ltd. | Laboratory & Allied Ltd | 100mg/500mg/375mg | 20 | Tablet | per tablet | KES 638 |
| Bispanol | Regal Pharmaceuticals | Regal Pharmaceuticals Limited | 10mg | 100 | Tablet | per tablet | KES 628.00 |
| Bispanol | Regal Pharmaceuticals | Regal Pharmaceuticals Limited | 10mg | 1000 | Tablet | per tablet | KES 5,891.00 |
| Bispanol | Regal Pharmaceuticals | Regal Pharmaceuticals Limited | 5mg | 60ml | Syrup | per 5ML | KES 107.00 |
| Bispanol | Regal Pharmaceuticals | Regal Pharmaceuticals Limited | 5mg | 100ml | Syrup | per 5ML | KES 158.00 |
| Bukol | Elys Chemicals Industries Ltd. | Elys Chemical Industries Ltd. | 10mg | 100 | Tablet | per tablet | KES 900.00 |
| Bukol | Elys Chemicals Industries Ltd. | Elys Chemical Industries Ltd. | 10mg | 1000 | Tablet | per tablet | KES 4,500.00 |
| Concepan | Concept (Africa) Limited | Concept (Africa) Limited | 5mg | 60ml | Syrup | per 5ML | KES 35.00 |
| Dividol | Remedica Ltd. | Twokay Chemicals Ltd | 10mg | 1000 | Tablet | per tablet | KES 3,200.00 |
| Hycin | Dawa Limited | Dawa Limited | 10mg | 100 | Tablet | per tablet | KES 1,000.00 |
| Hycin | Dawa Limited | Dawa Limited | 10mg | 1000 | Tablet | per tablet | KES 9,000.00 |
| Hycin | Dawa Limited | Dawa Limited | 20mg | 1ml | Injection | per vial | KES 15.00 |
| Hyomide | Biopharma Laboratories Ltd. | Maxim Pharmaceuticals Ltd | 5mg | 100 | Tablet | per tablet | KES 1,200.00 |
| Hyomide | Biopharma Laboratories Ltd. | Maxim Pharmaceuticals Ltd | 5mg | 60ml | Syrup | per 5ML | KES 95.00 |
| Runil | Macs Pharmaceuticals | Mac?s Pharmaceuticals Ltd | 10mg | 100 | Tablet | per tablet | KES 276.00 |
| XSPAS | Neon Laboratories Ltd | Sai Pharmaceuticals Ltd. | 20mg | 10 | Injection | per vial | KES 224.00 |
|
Hyoscine-N-butylbromide More info |
|
|---|---|
| Drug Indication | Paroxysmal and colicky pain in renal, billiary, GI, dysmenorhoea conditions. |
| Precautions | Myasthenia gravis, renal and hepatic impairment, children, elderly, diarrhoea, glaucoma, hypertension, ulcerative colitis, Downs syndrome. |
| Contra-Indications | Prostate enlargement, paralytic ileus, pyloric stenosis, high ambient temperatures. |
| Side Effects | GI disturbances, staggering, skin rashes, conjunctivitis, retrosternal pain. Anticholinergic side effects: dry mouth/skin, difficult in swallowing, visual disturbances, flushings, and drowsiness. |
| Dosage | Orally: adults; 20mg QID, child 6-12 years; 5-10mg TID, infants; 5mg TID. I.M: Acute spasm: 20mg repeated over 30 minutes when required. |
| Special Information | It is also known as butyl scopolamine or butyl hyoscine. Butyl-bromide moiety prevents the movement of this drug across the blood-brain barrier. This minimizes CNS side-effects associated with scopolamine / hyoscine. |
| Pregnancy Category | Category B2 |
| Pregnancy Category Description | Drugs which have been taken by only a small number of pregnant women and women of child-bearing age with no any established rise in the frequency of malformations or other direct or indirect detrimental effects on the foetus having been noted. Studies in animals are inadequate or lacking but available data show no evi-dence of an increased occurrence of foetal damage. Studies in animals are inadequate or lacking but available data show no evi-dence of an increased occurrence of foetal damage. |
| Drug Category | DRUGS ACTING ON ALIMENTARY SYSTEM |
| Drug Sub-Category | Antispasmodics
Use Oral: Adjunctive therapy for peptic ulcers, irritable bowel, neurogenic bladder/bowel; treatment of infant colic, GI tract disorders caused by spasm; to reduce rigidity, tremors, sialorrhea, and hyperhidrosis associated with parkinsonism; as a drying agent in acute rhinitis Injection: Preoperative antimuscarinic to reduce secretions and block cardiac vagal inhibitory reflexes; to improve radiologic visibility of the kidneys; symptomatic relief of biliary and renal colic; reduce GI motility to facilitate diagnostic procedures (ie, endoscopy, hypotonic duodenography); reduce pain and hypersecretion in pancreatitis, certain cases of partial heart block associated with vagal activity; reversal of neuromuscular blockade Adverse Reactions Sig Dosing: Adult Gastrointestinal spasms: Oral or S.L.: 0.125-0.25 mg every 4 hours or as needed (before meals or food); maximum: 1.5 mg/24 hours Oral, timed release: 0.375-0.75 mg every 12 hours; maximum: 1.5 mg/24 hours I.M., I.V., SubQ: 0.25-0.5 mg; may repeat as needed up to 4 times/day, at 4-hour intervals Diagnostic procedures: I.V.: 0.25-0.5 mg given 5-10 minutes prior to procedure Preanesthesia: I.V.: 5 mcg/kg given 30-60 minutes prior to induction of anesthesia or at the time preoperative narcotics or sedatives are administered To reduce drug-induced bradycardia during surgery: I.V.: 0.125 mg; repeat as needed Reverse neuromuscular blockade: I.V.: 0.2 mg for every 1 mg neostigmine (or the physostigmine/pyridostigmine equivalent) Dosing: Pediatric Gastrointestinal disorders: Children <2 years: Oral: Dose as listed, based on age and weight (kg) using the 0.125 mg/mL drops. Repeat dose every 4 hours as needed: 3.4 kg: 4 drops; maximum: 24 drops/24 hours 5 kg: 5 drops; maximum: 30 drops/24 hours 7 kg: 6 drops; maximum: 36 drops/24 hours 10 kg: 8 drops; maximum: 48 drops/24 hours Children 2-12 years: Oral or S.L.: Dose as listed, based on age and weight (kg); repeat dose every 4 hours as needed: 10 kg: 0.031-0.033 mg; maximum: 0.75 mg/24 hours 20 kg: 0.0625 mg; maximum: 0.75 mg/24 hours 40 kg: 0.0938 mg; maximum: 0.75 mg/24 hours 50 kg: 0.125 mg; maximum: 0.75 mg/24 hours Preanesthesia: Children >2 years: I.V.: Refer to adult dosing. Dosing: Geriatric Refer to adult dosing |